FYI- Dietary Supplements Recalled Due to Salmonella Contamination

According to the U.S. Food and Drug Administration, Eclectic Institute is voluntarily recalling specific lots of its freeze-dried capsules containing Gotu Kola (Centella asiatica) and Bladderwrack (Fucus vesiculosus) capsules because of potential Salmonella contamination.

Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. In rare circumstances, Salmonella infection can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

Eclectic Institute sold the recalled products to retailers, individuals, and health practitioners throughout the United States. The products that are subject of this voluntary recall were sold by several different methods.

The affected lots of Gotu Kola (Centella asiatica) products were sold from September 14, 2011 to December 14, 2011. The affected lots of Bladderwrack (Fucus vesiculosus) products were sold from July 14, 2011 to December 14, 2011.

Eclectic issued this voluntary recall because a routine audit of micro-testing records revealed that the micro-tests for one batch of Gotu Kola and one batch of Bladderwrack had conflicting lab results – one positive and one negative for Salmonella.

Bladderwrack is used to treat thyroid disorders and other ailments. It is used in Europe as an additive and flavoring and is frequently found in kelp tablets. Gotu kola has been used medicinally in China, India and elsewhere to treat a number of conditions, including ulcers, epilepsy, diarrhea and fever.

Mark Oppenheimer, a company spokesman, said the bladderwrack was culled off the coast of Oregon. The company’s gotu kola comes from an organic farm in Hawaii. Eclectic Institute sent letters to its customers, informing them of the recall. It also called all of the affected stores in Oregon, he said.

The 30-year-old company with 50 employees has never had a recall before, Oppenheimer said. This one follows a surprise visit by Food and Drug Administration inspectors, who are cracking down on dietary supplement companies that largely fell under the radar in the past.

Oppenheimer said Eclectic Institute tests lots before distribution for common foodborne pathogens, such as E. coli 0157:H7 and salmonella. In the past, when harmful bacteria showed up, it had the plants retested, fearing false positives. But in the future, it will order a recall or not distribute plants after a positive test.

According to the recall notice, no adverse effects or illnesses have been reported to date in connection with the recalled supplements.

This recall affects only specific products listed on the FDA website.  No other Eclectic Institute products are affected by this recall. All of the freeze-dried capsules were packaged in either glass or plastic bottles. Lot numbers can be found on the bottom of the label of the product.

Consumers in possession of any of the voluntarily recalled products are urged to return the product to Eclectic Institute’s headquarters in Sandy, Oregon, for a full refund.



,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Paxil Possibly Linked To Breast Cancer Risk

Cancer researchers from the City of Hope National Medical Center announced a possible link between Paxil and breast cancer. Research focused on Paxil’s estrogen effect Researchers found that Paxil has a weak estrogen effect that could increase women’s breast cancer risks. According to lead author and chairman of City of Hope’s Department of Cancer and […]

Big Pharma under Fire for Kickbacks to Docs

Trust and honesty are the cornerstones to a doctor-patient relationship. With so many doctors receiving financial incentives to use certain medications or medical devices, patients need to know if money drives the decision making process. Doctors are required to disclose potential financial conflicts to each other at conferences, but there currently is no law forcing […]

Dietary Supplements Damage Liver

A recent study revealed a significant increase in liver damage related to dietary supplements. The study, conducted by a national network of liver specialists, found a 13% increase in serious liver damage over a 10 year span. Some of these patients required liver transplants and some have even died due to liver failure. Authors of […]

FDA Advisory Committee Supports Approval of Gilead’s HIV Reducing Drug

The pharmaceutical industry may be on the verge of one of the greatest breakthrough’s that this generation has ever seen.

U.S. Health Regulators Issue New Restrictions For Gilenya, Novartis AG’s’ Multiple Sclerosis Pill

In December 2011, the FDA issued a Drug Safety Communication concerning a patient with multiple sclerosis (MS) who died within 24 hours of taking the first dose of Gilenya (fingolimod).

Latest Medical Device Injury News

Report Raises Concerns Over Heart Defibrillator Leads

The Food and Drug Administration (FDA) has just announced that they received a report that a St. Jude Durata cardiac defibrillator lead conductor became externalized; meaning the wire carrying electricity from the heart defibrillator to the heart was exposed through its insulation, a potentially dangerous and life-threatening defect.

HeartSine Class 1 Defibrillator Recall

HeartSine sent out a letter to customers in September, warning that the defibrillators may intermittently turn on and off, eventually depleting the battery.

FDA Medical Device Approval Based On Little Evidence

More than half of the high-risk cardiovascular devices approved in the past decade had no supporting active control data.

St. Jude Medical Gets FDA Warning

St. Jude Medical Inc. said it received a FDA warning about manufacturing and quality-control problems at its Sylmar, California, plant.

Hospira Still Facing Manufacturing And Regulatory Issues

Hospira has sent out 11 device notifications so far in 2013, including recall and device corrections. The company also said it sent notices to customers about some of its infusion pumps that had to either be recalled, fixed or adjusted.